13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001496201
Total reported value
$766.5M
$766.5M
97 檔
22.6%
In Q1 2024, Sphera Funds Management LTD.'s U.S. equity holdings reached a combined market value of $766.5M, distributed across 97 disclosed stock positions.
In Q1 2024, Sphera Funds Management LTD. displayed an active expansion posture, initiating 14 new positions and adding to 14 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 9.96% | +1.19% | +33.82% | |
| 2 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 5.07% | -0.96% | -24.00% | |
| 3 | SNY | Sanofi-adr | Stock-Healthcare | 3.41% | -0.56% | — | |
| 4 | NICE | Nice LTD - Spon Adr | Stock-Tech | 3.14% | -0.10% | EXIT | |
| 5 | CYTK | Cytokinetics Inc | Stock-Healthcare | 2.77% | +0.43% | +8.49% | |
| 6 | BBIO | Bridgebio Pharma Inc | Stock-Healthcare | 2.76% | -0.51% | +125.40% | |
| 7 | SNDX | Syndax Pharmaceuticals Inc | Stock-Other | 2.72% | +0.20% | +5.17% | |
| 8 | BIIB | Biogen Inc | Stock-Healthcare | 2.14% | +2.85% | +52.43% | |
| 9 | JSPR | Jasper Therapeutics Inc | Stock-Other | 2.08% | — | — | |
| 10 | ISREUR | Isoray Inc | Stock-Other | 2.08% | — | +48373.46% | |
| 11 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.93% | -0.13% | +46.01% | |
| 12 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.92% | +0.05% | -16.18% | |
| 13 | KURA | Kura Oncology Inc | Stock-Other | 1.83% | +0.04% | -13.15% | |
| 14 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.81% | — | +5.55% | |
| 15 | S | Sentinelone Inc -class A | Stock-Tech | 1.80% | — | +158.09% | |
| 16 | JNJ | Johnson & Johnson | Stock-Healthcare | 1.77% | -0.16% | — | |
| 17 | META | Meta Platforms Inc-class A | Stock-Comm Services | 1.74% | — | -25.84% | |
| 18 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.63% | -0.06% | -35.78% | |
| 19 | MSFT | Microsoft CORP | Stock-Tech | 1.63% | — | +15.51% | |
| 20 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.55% | -0.06% | — | |
| 21 | PRAX | Praxis Precision Medicines I | Stock-Other | 1.52% | +0.55% | NEW | |
| 22 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 1.50% | +0.05% | -10.74% | |
| 23 | CYBNEUR | Cybin Inc | Stock-Other | 1.49% | — | — | |
| 24 | ✓ | Inozyme Pharma Inc | Stock-Other | 1.48% | — | -12.16% | |
| 25 | FROG | JFrog Ltd. | Stock-Tech | 1.39% | — | +104.16% | |
| 26 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 1.38% | -1.06% | EXIT | |
| 27 | ✓ | Fusion Pharmaceuticals Inc | Stock-Other | 1.35% | — | -58.64% | |
| 28 | PHVS | Pharvaris N.V. | Stock-Other | 1.28% | — | +60.36% | |
| 29 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 1.19% | -0.59% | -11.40% | |
| 30 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 1.14% | — | -3.97% | |
| 31 | GLBE | Global-E Online Ltd. | Stock-Other | 1.07% | — | -22.61% | |
| 32 | WIX | Wix.com Ltd. | Stock-Tech | 1.02% | — | -8.00% | |
| 33 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.01% | — | +42.97% | |
| 34 | ✓ | Immatics NV | Stock-Other | 0.98% | -0.14% | +7.25% | |
| 35 | ABBV | Abbvie Inc | Stock-Healthcare | 0.97% | -0.05% | -17.39% | |
| 36 | OTLK | Outlook Therapeutics Inc | Stock-Other | 0.96% | — | — | |
| 37 | ✓ | Merus N V | Stock-Other | 0.94% | — | -35.17% | |
| 38 | AMAT | Applied Materials Inc | Stock-Tech | 0.93% | +1.04% | NEW | |
| 39 | CAMT | Camtek Ltd. | Stock-Other | 0.88% | -1.28% | EXIT | |
| 40 | NVMI | Nova Ltd. | Stock-Other | 0.87% | -1.90% | -73.40% | |
| 41 | TSEM | Tower Semiconductor Ltd. | Stock-Tech | 0.84% | -0.38% | -66.00% | |
| 42 | ETNBGBP | 89bio Inc | Stock-Other | 0.84% | — | +26.23% | |
| 43 | VIGL | Vigil Neuroscience Inc | Stock-Other | 0.83% | — | +223.37% | |
| 44 | ENPH | Enphase Energy Inc | Stock-Tech | 0.80% | -0.86% | EXIT | |
| 45 | VTYXUSD | Ventyx Biosciences Inc | Stock-Other | 0.77% | — | +451.53% | |
| 46 | TBLA | Taboola.com Ltd. | Stock-Other | 0.74% | — | -30.95% | |
| 47 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.73% | — | — | |
| 48 | INCY | Incyte CORP | Stock-Healthcare | 0.72% | — | — | |
| 49 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 0.70% | — | -3.70% | |
| 50 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 0.68% | +0.12% | -16.67% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TEVA | Teva Pharmaceutical-sp Adr | +3.7% | +33.82% | Add |
| 2 | JSPR | Jasper Therapeutics Inc | +2.1% | NEW | New buy |
| 3 | ISREUR | Isoray Inc | +2.1% | +48373.46% | Add |
| 4 | PRAX | Praxis Precision Medicines I | +1.5% | NEW | New buy |
| 5 | CYBNEUR | Cybin Inc | +1.5% | NEW | New buy |
| 6 | NICE | Nice LTD - Spon Adr | +1% | +26.82% | Add |
| 7 | OTLK | Outlook Therapeutics Inc | +1% | NEW | New buy |
| 8 | BBIO | Bridgebio Pharma Inc | +0.9% | +125.40% | Add |
| 9 | AMAT | Applied Materials Inc | +0.9% | NEW | New buy |
| 10 | CAMT | Camtek Ltd. | +0.9% | NEW | New buy |
| 11 | S | Sentinelone Inc -class A | +0.9% | +158.09% | Add |
| 12 | FROG | JFrog Ltd. | +0.8% | +104.16% | Add |
| 13 | FDMT | 4d Molecular Therapeutics In | +0.7% | NEW | New buy |
| 14 | VTYXUSD | Ventyx Biosciences Inc | +0.7% | +451.53% | Add |
| 15 | IRON | Disc Medicine Inc | +0.7% | NEW | New buy |
| 16 | CPRX | Catalyst Pharmaceuticals Inc | +0.6% | NEW | New buy |
| 17 | APLT | Applied Therapeutics Inc | +0.6% | NEW | New buy |
| 18 | ACAD | Acadia Pharmaceuticals Inc | +0.6% | NEW | New buy |
| 19 | AKRO | Akero Therapeutics Inc | +0.6% | NEW | New buy |
| 20 | VIGL | Vigil Neuroscience Inc | +0.5% | +223.37% | Add |
| 21 | ALEC | Alector Inc | +0.5% | NEW | New buy |
| 22 | AAPL | Apple Inc | +0.4% | NEW | New buy |
| 23 | ✓ | Inozyme Pharma Inc | +0.4% | -12.16% | Trim |
| 24 | SRPT | Sarepta Therapeutics Inc | +0.4% | +42.97% | Add |
| 25 | RARE | Ultragenyx Pharmaceutical In | +0.4% | +46.01% | Add |
| 26 | LLY | Eli Lilly & Co | +0.2% | — | Unchanged |
| 27 | BIIB | Biogen Inc | +0.2% | +52.43% | Add |
| 28 | KURA | Kura Oncology Inc | +0.2% | -13.15% | Trim |
| 29 | MSFT | Microsoft CORP | +0.2% | +15.51% | Add |
| 30 | SNDX | Syndax Pharmaceuticals Inc | 0% | +5.17% | Add |
| 31 | AMLX | Amylyx Pharmaceuticals Inc | -0.5% | +78.83% | Add |
| 32 | NVLSEUR | Alpine Immune Sciences Inc | -0.5% | -80.91% | Trim |
| 33 | SWTXUSD | Springworks Therapeutics Inc | -0.5% | -58.73% | Trim |
| 34 | PTCT | Ptc Therapeutics Inc | -0.6% | EXIT | Sold out |
| 35 | ENPH | Enphase Energy Inc | -0.6% | -29.47% | Trim |
| 36 | GLBE | Global-E Online Ltd. | -0.7% | -22.61% | Trim |
| 37 | ARWR | Arrowhead Pharmaceuticals In | -0.7% | EXIT | Sold out |
| 38 | PANW | Palo Alto Networks Inc | -0.8% | EXIT | Sold out |
| 39 | ✓ | Gracell Biotechnologies-adr | -0.8% | EXIT | Sold out |
| 40 | ✓ | Jasper Therapeutics Inc | -0.9% | EXIT | Sold out |
| 41 | AMD | Advanced Micro Devices | -0.9% | -78.17% | Trim |
| 42 | MDGL | Madrigal Pharmaceuticals Inc | -1% | EXIT | Sold out |
| 43 | CLDX | Celldex Therapeutics Inc | -1.1% | -35.78% | Trim |
| 44 | PRAX | Praxis Precision Medicines, Inc. | -1.2% | EXIT | Sold out |
| 45 | CATBUSD | Astria Therapeutics Inc | -1.2% | -90.20% | Trim |
| 46 | ALNY | Alnylam Pharmaceuticals Inc | -1.3% | -64.43% | Trim |
| 47 | INBXUSD | Inhibrx Inc | -1.4% | EXIT | Sold out |
| 48 | TSEM | Tower Semiconductor Ltd. | -1.8% | -66.00% | Trim |
| 49 | NVMI | Nova Ltd. | -2.1% | -73.40% | Trim |
| 50 | XBI | Ss Spdr S&p Biotech ETF | -2.1% | -24.00% | Trim |
According to official SEC Form 13F filings, Sphera Funds Management LTD. reported a total U.S. public equity portfolio value of $766.5M across 97 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TEVA, XBI, SNY) accounted for 22.6% of total reported equity market value during Q1 2024.
Top New Position Initiated
JSPR
市值: $14.8M
Top Position Liquidated / Trimmed
INBXUSD
前期市值: $8.6M
During Q1 2024, Sphera Funds Management LTD.'s top holdings by market value included TEVA (10.0%)、XBI (5.1%)、SNY (3.4%). The largest single position, TEVA, represented 10.0% of total portfolio value.
In Q1 2024, Sphera Funds Management LTD. made 49 total portfolio adjustments, initiating 14 new buys, adding to 14 positions, trimming 13 holdings, and fully liquidating 8 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.